CHITOSE will participate in BioJapan 2026, held from October 7th to October 9th at PACIFICO Yokohama.
We will showcase our cell line development technologies across three dedicated formats: a technical presentation, an interactive exhibition booth, and one-on-one business partnering sessions.

Presentation:
Dr. Takayuki Horiuchi (Chief Technology Officer, CHITOSE), will give a presentation on our optimized intensified cell culture processes.
・Title: Advanced CHO-MK Cell Technology: Achieving 10 g/L Antibody Yields in 5 Days in a Bioreactor
・Time: Wednesday, October 7th, 2026 | 10:20 AM – 10:50 AM
・Location: Presentation Stage B

Exhibition Booth & Partnering
Visit our biopharmaceutical manufacturing team at Booth #B-19 to discuss how CHITOSE‘s services and proprietary host cell lines (CHO-MK and HAT cells) can support your pipeline development.

Exhibition Booth: #B-19
Partnering Sessions: For a one-on-one meeting, please reach out via the BioJapan Partnering system or directly at the email address below:
biologics.contact◎chitose-bio.com
*replace ◎ with @

Event Overview
Event: BioJapan 2026
Dates: Wednesday, October 7 – Friday, October 9, 2026
Location: PACIFICO Yokohama, Japan

About CHITOSE’s Cell Line Development Service
https://biologics.chitose-bio.com/
Through over 10 years of research, CHITOSE has developed the highly productive CHO-MK host cell line and designed the original Chitose Super CHO expression system (CS CHO). With the combination of these innovations, we have established an extremely robust and flexible system to address the needs for a faster and more cost-effective cell line-based protein expression platform.